(in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | $1195 | $1120 | $1113 | $1017 |
Inventory | $106 | $126 | $116 | $114 |
Total current assets | $2616 | $2402 | $2317 | $2212 |
Long term investments | ||||
Property, plant & equipment | $708 | $703 | $706 | $673 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $8991 | $8545 | $8150 | $8010 |
Current liabilities | ||||
Accounts payable | $246 | $300 | $249 | $282 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $3745 | $3539 | $3290 | $3187 |
Long term debt | $4004 | $3964 | $3988 | $3986 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $8528 | $8238 | $7869 | $7758 |
Shareholders' equity | ||||
Retained earnings | -$1317 | -$1387 | -$1450 | -$1488 |
Other shareholder equity | -$260.14 | -$322.1 | -$277 | -$261 |
Total shareholder equity |
(in millions $) | 31 Jan 2024 | 30 Oct 2022 | 31 Oct 2021 | 29 Oct 2020 |
---|---|---|---|---|
Current assets | ||||
Cash | $0.46 | $553 | ||
Short term investments | ||||
Net receivables | $1120 | $984 | $0.15 | $771 |
Inventory | $126 | $108 | $99 | $79 |
Total current assets | $2402 | $2139 | $1.23 | $1678 |
Long term investments | ||||
Property, plant & equipment | $703 | $641 | $3.27 | $331 |
Goodwill & intangible assets | ||||
Total noncurrent assets | $4732 | |||
Total investments | ||||
Total assets | $8545 | $7828 | $4.51 | $6410 |
Current liabilities | ||||
Accounts payable | $300 | $268 | $3.02 | $264 |
Deferred revenue | $297 | |||
Short long term debt | $0.19 | $0.3 | ||
Total current liabilities | $3539 | $3368 | $10.89 | $2720 |
Long term debt | $3964 | $3732 | $0.39 | $3104 |
Total noncurrent liabilities | $3735 | |||
Total debt | ||||
Total liabilities | $8238 | $7676 | $11.28 | $6455 |
Shareholders' equity | ||||
Retained earnings | -$1387 | -$1477 | -$52.13 | -$1749 |
Other shareholder equity | -$322.1 | -$347 | $0.33 | -$204 |
Total shareholder equity | -$6.77 | -$2.08 |
(in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $1586 | $1564 | ||
Cost of revenue | ||||
Gross Profit | $741 | $714 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $530 | $525 | ||
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $58 | $43 | ||
Interest expense | -$36 | -$38 | ||
Net income | ||||
Net income | $150 | $120 | ||
Income (for common shares) |
(in millions $) | 31 Jan 2024 | 30 Oct 2022 | 31 Jan 2022 | 29 Oct 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $5919 | $4463 | ||
Cost of revenue | ||||
Gross Profit | $2839 | $2130 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $2125 | $2359 | ||
Operating income | -$229 | |||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $185 | $23 | ||
Interest expense | -$125 | $127 | ||
Net income | ||||
Net income | $551 | -$475 | ||
Income (for common shares) |
(in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$92 | -$300 | -$104 | -$51 |
Financing activities | ||||
Dividends paid | -$89 | -$340 | -$251 | -$167 |
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$93 | -$325 | -$233 | -$143 |
Effect of exchange rate | $5 | -$5 | $4 | $8 |
Change in cash and equivalents | $113 | $57 | $16 | $17 |
(in millions $) | 30 Oct 2023 | 30 Oct 2022 | 31 Oct 2021 | 29 Oct 2020 |
---|---|---|---|---|
Net income | -$23.55 | -$470 | ||
Operating activities | ||||
Depreciation | $0.23 | |||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | -$6.37 | $463 | ||
Investing activities | ||||
Capital expenditures | -$2.06 | |||
Investments | ||||
Total cash flows from investing | -$300 | -$824 | -$2.07 | -$219 |
Financing activities | ||||
Dividends paid | -$340 | -$318 | -$344 | |
Sale and purchase of stock | $7.33 | |||
Net borrowings | $1.31 | |||
Total cash flows from financing | -$325 | $188 | $8.85 | -$316 |
Effect of exchange rate | -$5 | -$21 | $0.01 | $6 |
Change in cash and equivalents | $57 | $85 | $0.42 | -$66 |
Heart-healthy, lower sodium version of traditional Chinese cuisine lowered blood pressure
NewMediaWire via Yahoo Finance
11 Jul 2022
|
Tech Industry Celebrates Earth Day 2022
Forbes
25 Apr 2022
|
Analysts Are Recommending These 10 Commodity Stocks
Insider Monkey via Yahoo Finance
22 Mar 2022
|
10 Fertilizer Stocks to Buy Today
Insider Monkey via Yahoo Finance
22 Mar 2022
|
Commentary: We can't have national security without a renaissance in US manufacturing
The Post and Courier
21 Jan 2022
|
Grutz: Changing seasons' effects on your immune system
telegraphherald.com
15 Nov 2021
|
This American Destroyer Saw Almost All of World War II—And It Just Couldn't Be Sunk
The National Interest via Yahoo News
10 Oct 2020
|
Market cap | $56.95M |
---|---|
Enterprise value | N/A |
Shares outstanding | 517.74M |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 0.70 |
Quick ratio | 0.67 |